Aldosterone antagonists in the treatment of hypertension and target organ damage
- 1 June 2001
- journal article
- review article
- Published by Springer Nature in Current Hypertension Reports
- Vol. 3 (3) , 240-248
- https://doi.org/10.1007/s11906-001-0046-2
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Mineralocorticoid actionSteroids, 2000
- Inhibition of Adrenal Cell Aldosterone Synthesis by Endogenous Nitric Oxide ReleaseHypertension, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Vascular Aldosterone in Genetically Hypertensive RatsHypertension, 1997
- High Affinity NAD+-dependent 11β-hydroxysteroid Dehydrogenase in the Human HeartJournal of Molecular and Cellular Cardiology, 1996
- Aldosterone inhibits nitric oxide synthesis in rat vascular smooth muscle cells induced by interleukin-1 βEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Production of Aldosterone in Isolated Rat Blood VesselsHypertension, 1995
- Rapid Effects of Aldosterone on Free Intracellular Calcium in Vascular Smooth Muscle and Endothelial Cells: Subcellular Localization of Calcium Elevations by Single Cell ImagingBiochemical and Biophysical Research Communications, 1994
- Estrogen Receptor-Associated Proteins: Possible Mediators of Hormone-Induced TranscriptionScience, 1994
- Vasodilation to acetylcholine in primary and secondary forms of human hypertension.Hypertension, 1993